Publications by authors named "Elise Pesonel"
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol.
Rindra Vatosoa Randremanana Mihaja Raberahona Mamy Jean de Dieu Randria Josephine Bourner Gabriella Zadonirina Elise Pesonel
Trials
July 2024
This article reports an update to the protocol of the IMASOY trial, which was prospectively registered on clinicaltrials.gov (NCT04110340) in October 2019.
View Article and Find Full Text PDFArticle Synopsis
- Human mpox, caused by the human mpox virus (hMPXV), typically leads to fever and rash and has seen an unprecedented global outbreak since May 2022, prompting the MOSAIC study to assess clinical outcomes.
- MOSAIC recruits participants of all ages with confirmed mpox, collecting various samples for PCR testing and clinical data over six months to understand the disease better.
- The study quickly commenced within two months of the outbreak, focusing on effective research responses to emerging diseases, with final follow-ups expected in January 2024.